Cantil

Active Ingredient(s): Mepenzolate
FDA Approved: * November 14, 1956
Pharm Company: * SANOFI AVENTIS US
Category: Ulcer

Mepenzolate is an antimuscarinic.[1] References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cantil 25 mg Oral Tablet

NDC: 0068-0037

Labeler:

Sanofi-aventis U.S. LLC